VEGFA and colorectal carcinoma: EGCG inhibits the expression of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor-1alpha (HIF-1α), both of which promote tumoral angiogenesis, thus suppressing CRC cell growth [42].